Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers

Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.387
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley